Business Description
Synlogic Inc
NAICS : 325412
SIC : 2834
ISIN : US87166L2097
Total Employee Number:
1Description
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. The pipeline drug candidates includes: labafenogene marselecobac (SYNB1934); SYNB1353 Classical Homocystinuria (HCU); SYNB8802 Enteric Hyperoxaluria; and SYNB2081 Gout. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one operating segment: Discovery and development of Synthetic Biotics.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.86 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 72.2 | |||||
3-Year EPS without NRI Growth Rate | 74.5 | |||||
3-Year FCF Growth Rate | 69.1 | |||||
3-Year Book Growth Rate | -62.1 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 7.08 | |||||
Quick Ratio | 7.08 | |||||
Cash Ratio | 6.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -38 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -5.3 | |||||
ROA % | -3.91 | |||||
ROIC % | -115.44 | |||||
3-Year ROIIC % | -190.63 | |||||
ROCE % | -31.33 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 0.63 | |||||
Price-to-Tangible-Book | 0.64 | |||||
EV-to-EBIT | 2.81 | |||||
EV-to-EBITDA | 2.81 | |||||
EV-to-Forward-Revenue | 44.13 | |||||
EV-to-FCF | 3.28 | |||||
Price-to-GF-Value | 22.69 | |||||
| Price-to-Net-Current-Asset-Value | 0.64 | |||||
| Price-to-Net-Cash | 0.66 | |||||
Earnings Yield (Greenblatt) % | 35.61 | |||||
FCF Yield % | -40.6 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Synlogic Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.052 | ||
| Beta | 0.7107 | ||
| 3-Year Sharpe Ratio | -0.63 | ||
| 3-Year Sortino Ratio | -0.64 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (€) | - | ||
| 20-Day SMA (€) | 3.63 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 3.63 - 3.63 | ||
| Shares Outstanding (Mil) | 11.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Synlogic Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Synlogic Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-12-15 09:00 | In 169 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 136 days | ||
| Second quarter earnings results for 2026 | 2026-08-07 | In 38 days | ||
| First quarter earnings results for 2026 | 2026-05-15 | 3.63 (+0.00%) | ||
| Annual report for 2025 | 2026-03-12 | 3.63 (+0.00%) | ||
| General meeting for 2025 | 2025-12-15 09:00 | 3.63 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-13 | 3.63 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-07 | 3.63 (+0.00%) | ||
| First quarter earnings results for 2025 | 2025-05-08 | 3.63 (+0.00%) | ||
| Annual report for 2024 | 2025-03-06 | 3.63 (+0.00%) |
Show
Entries
Synlogic Inc Frequently Asked Questions
What is Synlogic Inc(STU:MIN)'s stock price today?
The current price of STU:MIN is €3.63. The 52 week high of STU:MIN is €3.63 and 52 week low is €3.63.
When is next earnings date of Synlogic Inc(STU:MIN)?
The next earnings date of Synlogic Inc(STU:MIN) is 2026-08-07 Est..
Does Synlogic Inc(STU:MIN) pay dividends? If so, how much?
Synlogic Inc(STU:MIN) does not pay dividend.
Press Release
Articles on Synlogic Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers